Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
This is a 6-sequence, 3-period (8 weeks each), 3-arm, 24-week crossover study. The purpose of
this study is to provide information on the use of insulin lispro in insulin pumps
(Continuous Subcutaneous Insulin Infusion [CSII]) compared to insulin aspart over 6 days of
pump reservoir in-use. The study will also compare the in-use characteristics of insulin
lispro infused at 6 days with insulin lispro infused at 2 days.